mazindol has been researched along with Benign Supratentorial Neoplasms in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sadatomo, T | 1 |
| Sakoda, K | 1 |
| Yamanaka, M | 1 |
| Kutsuna, M | 1 |
| Kurisu, K | 1 |
1 other study available for mazindol and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Mazindol administration improved hyperphagia after surgery for craniopharyngioma--case report.
Topics: Appetite Depressants; Craniopharyngioma; Humans; Hyperphagia; Male; Mazindol; Middle Aged; Postopera | 2001 |